Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
RENO, Nev., March 27, 2026 (GLOBE NEWSWIRE) -- Aqua Metals, Inc. (NASDAQ: AQMS), a pioneer in battery metals recycling and refining, today announced it will report financial results for the fourth...
-
Auddia Announces Reverse Stock Split
-
WALTHAM, Mass., March 27, 2026 (GLOBE NEWSWIRE) -- Crescent Biopharma, Inc. (“Crescent” or the “Company”) (Nasdaq: CBIO), a clinical-stage biotechnology company dedicated to rapidly advancing the...
-
iAnthus Reports Fiscal Fourth Quarter and Full Year 2025 Financial Results
-
Apollo’s sales present a wide range of ancient art and jewellery spanning cultures across the ancient world, including Roman, Egyptian, and Near Eastern.
-
New York City, NY, March 27, 2026 (GLOBE NEWSWIRE) -- Something interesting is happening in the way Americans deal with foot pain. Instead of booking another $250 podiatrist appointment or...
-
EB613, the first oral anabolic (bone building) peptide tablet for postmenopausal women with osteoporosis – FDA Type A endpoint alignment in July 2025, Phase 3 protocol submitted to the FDA with...
-
NorthStrive Biosciences Signs Licensing Agreement Amendment with MOA Life Plus [KOSDAQ: 142760] for Dual Myostatin Assets Targeting Muscle Preservation in
-
Vera Therapeutics announces inducement grants Under Nasdaq Listing Rule 5635(c)(4).
-
BOSTON, March 27, 2026 (GLOBE NEWSWIRE) -- Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company developing a novel class of therapeutic biologics to selectively engage and...